title: Oral premalignant lesions: from a clinical perspective.
abstract: In this review article, the clinical and histopathological characteristics of oral premalignant lesions, and primarily oral leukoplakia, are noted and the risk factors for malignant transformation of oral leukoplakia are discussed. Malignant transformation rates of oral leukoplakia range from 0.13 to 17.5%. The risk factors of malignant transformation in the buccal mucosa and labial commissure are male gender with chewing tobacco or smoking in some countries such as India, or older age and/or being a non-smoking female in other countries. Some authors have reported that leukoplakia on the tongue or the floor of the mouth showed a high risk of malignant transformation, although others have found no oral subsites at high risk. In concurrence with some authors, the authors of this review view epithelial dysplasia as an important risk factor in malignant transformation; however, there are conflicting reports in the literature. Many authors believe that nonhomogeneous leukoplakia is a high risk factor without exception, although different terms have been used to describe those conditions. The large size of lesions and widespread leukoplakia are also reported risk factors. According to some studies, surgical treatment decreased the rate of malignant transformation; however, many review articles state that no definitive treatment including surgery can decrease the malignant transformation rate of oral leukoplakia because of the lack of randomized control trials of treatment. Tobacco chewing and smoking may be causative agents for cancerization of oral leukoplakia in some groups, and evidence for a role of human papilloma virus in the malignant transformation of oral leukoplakia is inconsistent. Further research to clarify its role in malignant transformation is warranted.
authors.affiliation: Maxillofacial Surgery, Graduate School, Tokyo Medical and Dental University, Yushima 1-chome, 5-45, Bunkyo-Ku, Tokyo 113-8549, Japan. amagasa.mfs@tmd.ac.jp
authors.forename: Teruo
authors.initials: T
authors.lastname: Amagasa
authors.forename: Masashi
authors.initials: M
authors.lastname: Yamashiro
authors.forename: Narikazu
authors.initials: N
authors.lastname: Uzawa
mesh_terms: D000328:Adult; D002471:Cell Transformation, Neoplastic / Q000473:pathology*; D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D007455:Iodine; D007642:Keratosis / Q000175:diagnosis / Q000473:pathology; D007972:Leukoplakia, Oral / Q000145:classification* / Q000209:etiology / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa / Q000473:pathology; D009062:Mouth Neoplasms / Q000145:classification* / Q000209:etiology / Q000473:pathology*; D027383:Papillomaviridae / Q000302:isolation & purification; D011230:Precancerous Conditions / Q000145:classification* / Q000209:etiology / Q000473:pathology*; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D014030:Tobacco, Smokeless / Q000009:adverse effects
chemical_list: D007455:Iodine